Abstract:Hepatic stellate cells (HSCs) activation is a critical event in the developing of hepatic fibrosis and even hepatocellular carcinoma (HCC). By the release of soluble cytokines, chemokines and chemotaxis, HSCs affect HCC cell phenotypes through a complex tumor microenvironment. In this study, weighted gene co‐expression network analysis (WGCNA) was used to identify TGF‐β signaling pathway as a key signaling pathway in Hep3B cells cultured in HSC conditioned medium. MIR4435‐2HG is a hub lncRNA associated with TGF‐β signaling pathway and HSC activation. HSC‐condition medium (CM) culture induced HCC cell malignant behaviors, which were partially reversed by MIR4435‐2HG silencing. miR‐506‐3p directly bound to MIR4435‐2HG and the 3'UTR of TGFB1. Similarly, overexpression of miR‐506‐3p also attenuated HSC‐CM‐induced malignant behavior of HCC cells. In HSC‐CM cultured HCC cells, the effects of MIR4435‐2HG knockdown on TGFB1 expression and HCC cell phenotypes were partially reversed by miR‐506‐3p inhibition. HSCs affected HCC cell phenotypes by releasing CXCL1. In an orthotopic xenotransplanted tumor model of HCC cells plus HSCs in mice, CXCR2 knockdown in HCC cells significantly inhibited tumorigenesis, which was partially reversed by MIR4435‐2HG overexpression in HCC cells. In HCC tissue samples, the levels of CXCL1, TGF‐β1, and MIR4435‐2HG were up‐regulated, while miR‐506‐3p expression was down‐regulated. In conclusion, HSC‐released CXCL1 aggravated HCC cell malignant behaviors through the MIR4435‐2HG/miR‐506‐3p/TGFB1 axis. In addition to CXCL1, the MIR4435‐2HG/miR‐506‐3p/TGFB1 axis might also be the underlying target for HCC therapy.

Hepatic stellate cell‐released CXCL1 aggravates HCC malignant behaviors through the MIR4435‐2HG/miR‐506‐3p/TGFB1 axis